{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:46:32Z","timestamp":1756809992691},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1362","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T23:20:34Z","timestamp":1396308034000},"page":"771-775","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune Hepatitis in a Patient with Pulmonary Arterial Hypertension Treated with Endothelin Receptor Antagonists"],"prefix":"10.2169","volume":"53","author":[{"given":"Akira","family":"Naito","sequence":"first","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Sakao","sequence":"additional","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Respirology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-S54, 2009.","DOI":"10.1016\/j.jacc.2009.04.012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hartman JC, Brouwer K, Mandagere A, Melvin L, Gorczynski R. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol 88: 682-691, 2010.","DOI":"10.1139\/Y10-060"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hoeper MM. Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 34: 529-530, 2009.","DOI":"10.1183\/09031936.00094409"},{"key":"4","unstructured":"4. Fattinger K, Funk C, Pantze M, et al. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69: 223-231, 2001."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Imbach P. Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review. Swiss Med Wkly 142: w13593, 2012.","DOI":"10.4414\/smw.2012.13593"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Halverscheid L, Deibert P, Schmidt R, et al. Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver. BMC Gastroenterol 9: 69, 2009.","DOI":"10.1186\/1471-230X-9-69"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48: 169-176, 2008.","DOI":"10.1002\/hep.22322"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsai CY, Huo AP, Chou CT, Wu TH, Tsai YY. Hepatitis, cholangitis, pulmonary hypertension, digital gangrene, and conjunctivitis sicca in a woman with anticentromere antibodies. Eur J Intern Med 17: 360-362, 2006.","DOI":"10.1016\/j.ejim.2006.02.003"},{"key":"9","unstructured":"9. Bertino G, Ardiri AM, Boemi PM, Ierna D, Pulvirenti D, Neri S. A case of overlap syndrome: autoimmune idiopathic hepatitis\/pulmonary idiopathic hypertension. Clin Ter 158: 313-315, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kaneko F, Yokomori H, Tahara K, Takeshita T, Takeuchi H, Yoshida H, et al. Autoimmune hepatitis associated with pulmonary arterial hypertension. Intern Med 47: 1971-1976, 2008.","DOI":"10.2169\/internalmedicine.47.1420"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Klein R, Hintz E, Staehler G. Exacerbation of AIH in a patient with an AIH\/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan. BMJ Case Rep published online 16 July, 2012.","DOI":"10.1136\/bcr-01-2012-5494"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Himoto T, Murota M, Yoneyama H, et al. Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody. Hepatol Res 40: 786-792, 2010.","DOI":"10.1111\/j.1872-034X.2010.00684.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 46: S2-S14, 2009.","DOI":"10.1053\/j.seminhematol.2008.12.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fujii H, Ohnishi N, Shimura K, et al. Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes. World J Gastroenterol 19: 1834-1840, 2013.","DOI":"10.3748\/wjg.v19.i11.1834"},{"key":"15","unstructured":"15. Dejica D. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Roum Arch Microbiol Immunol 60: 183-201, 2001."},{"key":"16","unstructured":"16. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 140: 1292-1299, 2011."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hoeper MM, Olsson KM, Schneider A, Golpon H. Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy. Eur Respir J 33: 1518-1519, 2009.","DOI":"10.1183\/09031936.00193308"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/7\/53_53.1362\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:50:41Z","timestamp":1621446641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/7\/53_53.1362\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1362","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}